UK Medicines Information
Nonmedical use of alprazolam in the UK: Results from a nationally representative survey
Information type:
Other primary research
Source:
British Journal of Clinical Pharmacology
Specialities:
Mental health and illness
Summary
Estimated national prevalence of lifetime nonmedical use (NMU) of alprazolam (AL) was 0.32% and 1.30% for diazepam. Prevalence of NMU in last 90 days was significantly different when split by age for AL (but not diazepam) with AL NMU being more common among younger adults.
UKMi comment
Related links: